AtriCure (ATRC) Scheduled to Post Quarterly Earnings on Tuesday

published 26.07.2020 04:00

Image of article 'AtriCure (ATRC) Scheduled to Post Quarterly Earnings on Tuesday'

JPMorgan Chase & Co. reduced their target price on AtriCure from $47.00 to $39.00 and set an “overweight” rating on the stock in a report on Tuesday, April 28th.

Canaccord Genuity lifted their target price on AtriCure from $41.00 to $45.00 and gave the stock a “buy” rating in a report on Thursday, April 30th.

Oppenheimer boosted their price objective on AtriCure from $45.00 to $52.00 and gave the stock an “outperform” rating in a research note on Monday, May 11th.

Finally, Needham & Company LLC reissued a “buy” rating and set a $49.00 price objective on shares of AtriCure in a research note on Friday, May 8th.

In other AtriCure news, Director Mark A. Collar sold 4,000 shares of the business’s stock in a transaction that occurred on Wednesday, July 1st.

by Xavier Holt from dispatchtribunal.com

Free awesomeness straight to your inbox!

Sign up now for this free newsletter to receive hand picked content, covering topics like Lifestyle, Business & Technology.

Free Newsletter Sign up now!

..or jump directly to the latest posts!